Clinical Trial Update: Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of intradermal versus intramuscular administration of HIV lipopeptides in HIV-uninfected adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV lipopeptides

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections, HIV Seronegativity | Phase 1 | Status: COMPLETED